Mobile  |  About us  |  Photos  |  Videos  |  Subscriptions  |  RSS Feeds  |  Today's Paper  |  Classifieds  |  Contact Us
The Daily Star
FRIDAY, 18 APR 2014
11:47 PM Beirut time
22 °C
Blom Index
Follow this story Print RSS Feed ePaper share this
US implant device helps prevent clotting: study
Agence France Presse
This undated image provided by Boston Scientific on Wednesday, Feb. 27, 2013 shows an experimental heart device called the Watchman. (AP Photo/Boston Scientific)
This undated image provided by Boston Scientific on Wednesday, Feb. 27, 2013 shows an experimental heart device called the Watchman. (AP Photo/Boston Scientific)
A+ A-

WASHINGTON:An implant device designed by US firm Boston Scientific to prevent strokes in high risk people helps avert blood clotting, a new study said.

The umbrella-shaped device called "Watchman" can also serve as an alternative to treatment with anticoagulants of patients suffering from arterial fibrillation, a study by the manufacturer said.

The trials involved 407 patients at 41 sites and compared the "Watchman" to warfarin, an anticoagulant medication, said the study, which was presented on Saturday.

Of the people surveyed, 269 used "Watchman" and 138 took the blood thinner warfarin.

The results show that "the device performed similar to warfarin with a rate ratio of 1.07", said the report, presented at an annual conference of the American College of Cardiology.

"The results ... add to the wealth of previously published data confirming the utility of the 'Watchmen' device as an option for the reduction of stroke in high risk patients," said Kenneth Stein, chief medical officer with the cardiac rhythm management department of Boston Scientific.

"'Watchman' is the only device-based alternative to anticoagulation that has undergone rigorous scientific study," he added.

"Watchman" is introduced into the heart via a catheter that goes through a vein in the groin.

Atrial fibrillation affects approximately 15 million patients worldwide. A Patients have a five times greater risk of stroke.

"Watchman" was approved for sale in Europe in 2005 and some countries in Asia in 2009, according to Boston Scientific.

The results of the study will be submitted to the US Food and Drug Administration as part of a process to obtain approval for its marketing in the United States.

Home Health
United States of America

Your feedback is important to us!

We invite all our readers to share with us their views and comments about this article.

Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.

comments powered by Disqus

Baabda 2014
Follow us on Facebook Follow us on Twitter Follow us on Linked In Follow us on Google+ Subscribe to our Live Feed
Pictures of the day
A selection of images from around the world- Friday April 18, 2014
View all view all
Rami G. Khouri
Rami G. Khouri
Silencing Ayaan Hirsi Ali’s hate talk
Michael Young
Michael Young
Why confuse gibberish with knowledge?
David Ignatius
David Ignatius
Putin will keep rolling, until Obama says no
View all view all
Click to View Articles
Privacy Policy | Anti-Spamming Policy | Disclaimer | Copyright Notice
© 2014 The Daily Star - All Rights Reserved - Designed and Developed By IDS